Company Description
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therap...
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Valuation
P/E Current
6.69
P/E Ratio (with extraordinary items)
6.63
P/E Ratio (without extraordinary items)
8.97
Price to Sales Ratio
5.95
Price to Book Ratio
7.24
Price to Cash Flow Ratio
8.05
Enterprise Value to EBITDA
4.67
Enterprise Value to Sales
2.96
Efficiency
Total Asset Turnover
1.14
Liquidity
Current Ratio
1.76
Quick Ratio
1.60
Cash Ratio
1.18
Profitability
Gross Margin
84.53
Operating Margin
71.89
Pretax Margin
72.15
Net Margin
66.27
Return on Assets
75.78
Return on Equity
146.08
Return on Total Capital
148.24
Capital Structure
Total Debt to Total Assets
3.68
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. Stéphane Bancel | 48 | - | President, Founding CEO & Director |
Dr. Stephen Hoge | 45 | - | SVP-Corporate Development & New Drug Concepts |
Mr. James M. Mock | 44 | 2022 | Chief Financial Officer |
Dr. Paul Burton | 52 | 2021 | Chief Medical Officer |
Mr. Juan Andres | 56 | 2017 | Chief Technical Operations & Quality Officer |
Insider Actions
01/05/2023 |
Stéphane Bancel Chief Executive Officer; Director |
975 | Disposition at $175.1 per share. | 170,722 |
01/05/2023 |
Stéphane Bancel Chief Executive Officer; Director |
13,460 | Disposition at $174.38 per share. | 2,347,154 |
01/05/2023 |
Stéphane Bancel Chief Executive Officer; Director |
14,816 | Disposition at $173.42 per share. | 2,569,390 |
01/05/2023 |
Stéphane Bancel Chief Executive Officer; Director |
10,749 | Disposition at $172.64 per share. | 1,855,707 |
01/05/2023 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
01/04/2023 |
Noubar B. Afeyan Director |
10,000 | Disposition at $182.15 per share. | 1,821,500 |
12/29/2022 |
Stéphane Bancel Chief Executive Officer; Director |
10,000 | Disposition at $178.19 per share. | 1,781,900 |
12/29/2022 |
Stéphane Bancel Chief Executive Officer; Director |
800 | Disposition at $182.13 per share. | 145,704 |
12/29/2022 |
Stéphane Bancel Chief Executive Officer; Director |
2,602 | Disposition at $181.07 per share. | 471,144 |
12/29/2022 |
Stéphane Bancel Chief Executive Officer; Director |
15,890 | Disposition at $180.25 per share. | 2,864,172 |
12/29/2022 |
Stéphane Bancel Chief Executive Officer; Director |
20,708 | Disposition at $179.31 per share. | 3,713,151 |
12/29/2022 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
10,000 | Disposition at $209.82 per share. | 2,098,200 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
759 | Disposition at $208.13 per share. | 157,970 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
2,872 | Disposition at $207.33 per share. | 595,451 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
9,093 | Disposition at $206.39 per share. | 1,876,704 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
11,981 | Disposition at $205.5 per share. | 2,462,095 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
8,379 | Disposition at $204.47 per share. | 1,713,254 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
6,216 | Disposition at $203.56 per share. | 1,265,328 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
700 | Disposition at $202.35 per share. | 141,645 |
12/22/2022 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
12/21/2022 |
Stéphane Bancel Chief Executive Officer; Director |
271 | Disposition at $210.16 per share. | 56,953 |
12/21/2022 |
Stéphane Bancel Chief Executive Officer; Director |
4,307 | Disposition at $209.3 per share. | 901,455 |
12/21/2022 |
Stéphane Bancel Chief Executive Officer; Director |
11,131 | Disposition at $208.66 per share. | 2,322,594 |
12/21/2022 |
Stéphane Bancel Chief Executive Officer; Director |
8,833 | Disposition at $207.46 per share. | 1,832,494 |
12/21/2022 |
Stéphane Bancel Chief Executive Officer; Director |
5,775 | Disposition at $206.64 per share. | 1,193,346 |
12/21/2022 |
Stéphane Bancel Chief Executive Officer; Director |
3,183 | Disposition at $205.51 per share. | 654,138 |
12/21/2022 |
Stéphane Bancel Chief Executive Officer; Director |
6,500 | Disposition at $203.46 per share. | 1,322,490 |
12/21/2022 |
Noubar B. Afeyan Director |
10,000 | Disposition at $201.7 per share. | 2,017,000 |
12/21/2022 |
Juan Andres See remarks |
2,000 | Disposition at $201.7 per share. | 403,400 |
12/21/2022 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
12/21/2022 |
Juan Andres See remarks |
2,000 | Derivative/Non-derivative trans. at $20.93 per share. | 41,860 |
12/15/2022 |
Stéphane Bancel Chief Executive Officer; Director |
10,000 | Disposition at $207.88 per share. | 2,078,800 |
12/15/2022 |
Stéphane Bancel Chief Executive Officer; Director |
200 | Disposition at $208.03 per share. | 41,606 |
12/15/2022 |
Stéphane Bancel Chief Executive Officer; Director |
20,200 | Disposition at $207.37 per share. | 4,188,874 |
12/15/2022 |
Stéphane Bancel Chief Executive Officer; Director |
1,700 | Disposition at $205.93 per share. | 350,081 |
12/15/2022 |
Stéphane Bancel Chief Executive Officer; Director |
10,091 | Disposition at $204.67 per share. | 2,065,324 |
12/15/2022 |
Stéphane Bancel Chief Executive Officer; Director |
7,809 | Disposition at $203.9 per share. | 1,592,255 |
12/15/2022 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
300 | Disposition at $216.76 per share. | 65,028 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
1,116 | Disposition at $216.1 per share. | 241,167 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
2,928 | Disposition at $215.07 per share. | 629,724 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
7,321 | Disposition at $214.09 per share. | 1,567,352 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
5,580 | Disposition at $213.06 per share. | 1,188,874 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
6,598 | Disposition at $212.13 per share. | 1,399,633 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
7,120 | Disposition at $211.17 per share. | 1,503,530 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
3,156 | Disposition at $210.12 per share. | 663,138 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
1,293 | Disposition at $209.03 per share. | 270,275 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
888 | Disposition at $207.99 per share. | 184,695 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
600 | Disposition at $206.49 per share. | 123,894 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
800 | Disposition at $204.47 per share. | 163,576 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
400 | Disposition at $203.17 per share. | 81,268 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
1,200 | Disposition at $200.65 per share. | 240,780 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
700 | Disposition at $199.88 per share. | 139,916 |
12/14/2022 |
Juan Andres See remarks |
2,000 | Disposition at $195 per share. | 390,000 |
12/14/2022 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
12/14/2022 |
Juan Andres See remarks |
2,000 | Derivative/Non-derivative trans. at $20.93 per share. | 41,860 |
12/08/2022 |
Stéphane Bancel Chief Executive Officer; Director |
10,000 | Disposition at $179.12 per share. | 1,791,200 |
12/08/2022 |
Stéphane Bancel Chief Executive Officer; Director |
1,038 | Disposition at $184.88 per share. | 191,905 |
12/08/2022 |
Stéphane Bancel Chief Executive Officer; Director |
7,622 | Disposition at $184.25 per share. | 1,404,353 |
12/08/2022 |
Stéphane Bancel Chief Executive Officer; Director |
19,078 | Disposition at $183.05 per share. | 3,492,227 |
12/08/2022 |
Stéphane Bancel Chief Executive Officer; Director |
12,262 | Disposition at $182.19 per share. | 2,234,013 |
12/08/2022 |
Shannon Thyme Klinger Chief Legal Officer |
490 | Disposition at $179.15 per share. | 87,783 |
12/08/2022 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
12/07/2022 |
Stéphane Bancel Chief Executive Officer; Director |
600 | Disposition at $180.11 per share. | 108,066 |
12/07/2022 |
Stéphane Bancel Chief Executive Officer; Director |
10,557 | Disposition at $179.49 per share. | 1,894,875 |
12/07/2022 |
Stéphane Bancel Chief Executive Officer; Director |
4,961 | Disposition at $178.23 per share. | 884,199 |
12/07/2022 |
Stéphane Bancel Chief Executive Officer; Director |
15,826 | Disposition at $177.3 per share. | 2,805,949 |
12/07/2022 |
Stéphane Bancel Chief Executive Officer; Director |
7,613 | Disposition at $176.56 per share. | 1,344,151 |
12/07/2022 |
Stéphane Bancel Chief Executive Officer; Director |
443 | Disposition at $175.26 per share. | 77,640 |
12/07/2022 |
Juan Andres See remarks |
2,000 | Disposition at $172.16 per share. | 344,320 |
12/07/2022 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
12/07/2022 |
Juan Andres See remarks |
2,000 | Derivative/Non-derivative trans. at $20.93 per share. | 41,860 |
12/07/2022 |
Shannon Thyme Klinger Chief Legal Officer |
1,139 | Derivative/Non-derivative trans. at $0 per share. | 0 |
12/01/2022 |
Stéphane Bancel Chief Executive Officer; Director |
10,000 | Disposition at $173.41 per share. | 1,734,100 |
12/01/2022 |
Stéphane Bancel Chief Executive Officer; Director |
1,804 | Disposition at $183.46 per share. | 330,961 |
12/01/2022 |
Stéphane Bancel Chief Executive Officer; Director |
7,832 | Disposition at $182.65 per share. | 1,430,514 |
12/01/2022 |
Stéphane Bancel Chief Executive Officer; Director |
6,321 | Disposition at $181.58 per share. | 1,147,767 |
12/01/2022 |
Stéphane Bancel Chief Executive Officer; Director |
12,331 | Disposition at $180.53 per share. | 2,226,115 |
12/01/2022 |
Stéphane Bancel Chief Executive Officer; Director |
11,712 | Disposition at $179.62 per share. | 2,103,709 |
12/01/2022 |
Stéphane Bancel Chief Executive Officer; Director |
40,000 | Derivative/Non-derivative trans. at $0.99 per share. | 39,600 |
MarketWatch News on MRNA
-
Moderna Inc. stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
FDA Advisers Recommend Replacing All Covid Vaccines With Bivalent Version
- Josh Nathan-Kazis
-
Moderna Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Tuesday, still outperforms market
- MarketWatch Automation
-
Moderna Inc. stock rises Monday, still underperforms market
- MarketWatch Automation
-
An Annual Covid Booster Could Be Coming. What It Means for Pfizer, Moderna.
- Josh Nathan-Kazis
-
Moderna Inc. stock rises Friday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Chegg, Bluebird Bio, Yeti, J.B. Hunt, and More Market Movers
- Emily Dattilo
-
Moderna Sees Success in RSV Vaccine Trial
- Josh Nathan-Kazis
- Loading more headlines...
Other News on MRNA
-
How Biden Officials Bungled a Better Vaccine
- Allysia Finley
-
FDA Advisers Back Annual Covid-19 Boosters With Reservations About Rollout
- Liz Essley Whyte
-
Top 5 4th Quarter Trades of ARS Investment Partners, LLC
- GuruFocus.com
-
Baillie Gifford Slashes Meta, Boosts Nvidia
- GuruFocus.com
-
Johnson & Johnson Profit Falls 25%
- Peter Loftus
-
The Deceptive Campaign for Bivalent Covid Boosters
- Allysia Finley
-
Stocks Fall After Retail and Inflation Data
- Joe Wallace
-
Moderna Finds Life After Covid-19
- David Wainer
-
A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them
- Jared S. Hopkins
-
J&J Slashes Production of Its Covid-19 Vaccine
- Jared S. Hopkins
-
Aurora Investment Managers, LLC. Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Old Port Advisors Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Moderna Considers Price of $110-$130 for Covid-19 Vaccine
- Peter Loftus
-
China to Allow Rapid Tests to Confirm Covid Cases
- Rachel Liang
-
Corporate Insiders Aren’t Betting on a Market Rebound
- Jack Pitcher
-
Western Covid Medicine to China’s Rescue
- The Editorial Board
-
Boring Was King of Healthcare in 2022
- David Wainer
- Loading more headlines...